ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
WHO, 2014. Malaria Vaccine Rainbow Tables. http://www.who.int/vaccine_research/links/Rainbow/en/index.html. Accessed September 3, 2014.
-
2.
Schwartz L, Brown GV, Genton B, Moorthy VS, 2012. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 11: 11.
-
3.
Dutta S, Lee SY, Batchelor AH, Lanar DE, 2007. Structural basis of antigenic escape of a malaria vaccine candidate. Proc Natl Acad Sci USA 104: 12488–12493.
-
4.
Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD, 2012. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. PLoS ONE 7: e43430.
-
5.
Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG Jr, Plowe CV, 2011. A field trial to assess a blood-stage malaria vaccine. N Engl J Med 365: 1004–1013.
-
6.
Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP, 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185: 820–827.
-
7.
Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, Felgner PL, Doumbo OK, Plowe CV, 2015. Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. Am J Trop Med Hyg 92: 9–12.
-
8.
Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traoré K, Niangaly A, Djimdé AA, Doumbo OK, Plowe CV, 2009. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med 1: 2ra5.
-
9.
Dutta S, Dlugosz LS, Drew DR, Ge X, Ababacar D, Rovira YI, Moch JK, Shi M, Long CA, Foley M, Beeson JG, Anders RF, Miura K, Haynes JD, Batchelor AH, 2013. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. PLoS Pathog 9: e1003840.
-
10.
Remarque EJ, Faber BW, Kocken CH, Thomas AW, 2008. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immun 76: 2660–2670.
-
11.
Faber BW, Younis S, Remarque EJ, Rodriguez Garcia R, Riasat V, Walraven V, van der Werff N, van der Eijk M, Cavanagh DR, Holder AA, Thomas AW, Kocken CH, 2013. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines. Infect Immun 81: 1479–1490.
-
12.
Malpede BM, Tolia NH, 2014. Malaria adhesins: structure and function. Cell Microbiol 16: 621–631.
-
13.
Barry AE, Arnott A, 2014. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol 28: 359.
-
14.
Kusi KA, Faber BW, Thomas AW, Remarque EJ, 2009. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity. PLoS ONE 4: e8110.
-
15.
Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B, 2011. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates. PLoS ONE 6: e16622.
-
16.
Simone O, Bejarano MT, Pierce SK, Antonaci S, Wahlgren M, Troye-Blomberg M, Donati D, 2011. TLRs innate immune receptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation. Acta Trop 119: 144–150.
-
17.
Scholzen A, Sauerwein RW, 2013. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol 29: 252–262.
-
18.
Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, Crompton PD, Marsh K, Ndungu FM, 2013. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol 190: 1038–1047.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 636 | 592 | 17 |
| Full Text Views | 260 | 18 | 1 |
| PDF Downloads | 39 | 6 | 1 |
Expanding the Toolbox in Pursuit of a Strain Transcendent Malaria Vaccine
Anne E.P. Frosch
Anne E.P. Frosch
Division of Infectious Diseases and International Medicine, Department of Medicine and Division of Global Pediatrics, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
Search for other papers by Anne E.P. Frosch in
Current site
Google Scholar
PubMed
Search for other papers by Anne E.P. Frosch in
Current site
Google Scholar
PubMed
Chandy C. John
Chandy C. John
Division of Infectious Diseases and International Medicine, Department of Medicine and Division of Global Pediatrics, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
Search for other papers by Chandy C. John in
Current site
Google Scholar
PubMed
Search for other papers by Chandy C. John in
Current site
Google Scholar
PubMed
Author Notes
Authors' addresses: Anne Parker Frosch and Chandy John, Departments of Medicine and Pediatrics, Divisions of Infectious Diseases and International Health, Center for Infectious Diseases and Microbiology Translational Research, and Global Pediatrics, University of Minnesota, Minneapolis, MN, E-mails: park0587@umn.edu and ccj@umn.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
WHO, 2014. Malaria Vaccine Rainbow Tables. http://www.who.int/vaccine_research/links/Rainbow/en/index.html. Accessed September 3, 2014.
-
2.
Schwartz L, Brown GV, Genton B, Moorthy VS, 2012. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 11: 11.
-
3.
Dutta S, Lee SY, Batchelor AH, Lanar DE, 2007. Structural basis of antigenic escape of a malaria vaccine candidate. Proc Natl Acad Sci USA 104: 12488–12493.
-
4.
Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD, 2012. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. PLoS ONE 7: e43430.
-
5.
Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG Jr, Plowe CV, 2011. A field trial to assess a blood-stage malaria vaccine. N Engl J Med 365: 1004–1013.
-
6.
Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP, 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185: 820–827.
-
7.
Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, Felgner PL, Doumbo OK, Plowe CV, 2015. Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. Am J Trop Med Hyg 92: 9–12.
-
8.
Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traoré K, Niangaly A, Djimdé AA, Doumbo OK, Plowe CV, 2009. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med 1: 2ra5.
-
9.
Dutta S, Dlugosz LS, Drew DR, Ge X, Ababacar D, Rovira YI, Moch JK, Shi M, Long CA, Foley M, Beeson JG, Anders RF, Miura K, Haynes JD, Batchelor AH, 2013. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. PLoS Pathog 9: e1003840.
-
10.
Remarque EJ, Faber BW, Kocken CH, Thomas AW, 2008. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immun 76: 2660–2670.
-
11.
Faber BW, Younis S, Remarque EJ, Rodriguez Garcia R, Riasat V, Walraven V, van der Werff N, van der Eijk M, Cavanagh DR, Holder AA, Thomas AW, Kocken CH, 2013. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines. Infect Immun 81: 1479–1490.
-
12.
Malpede BM, Tolia NH, 2014. Malaria adhesins: structure and function. Cell Microbiol 16: 621–631.
-
13.
Barry AE, Arnott A, 2014. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol 28: 359.
-
14.
Kusi KA, Faber BW, Thomas AW, Remarque EJ, 2009. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity. PLoS ONE 4: e8110.
-
15.
Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B, 2011. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates. PLoS ONE 6: e16622.
-
16.
Simone O, Bejarano MT, Pierce SK, Antonaci S, Wahlgren M, Troye-Blomberg M, Donati D, 2011. TLRs innate immune receptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation. Acta Trop 119: 144–150.
-
17.
Scholzen A, Sauerwein RW, 2013. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol 29: 252–262.
-
18.
Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, Crompton PD, Marsh K, Ndungu FM, 2013. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol 190: 1038–1047.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 636 | 592 | 17 |
| Full Text Views | 260 | 18 | 1 |
| PDF Downloads | 39 | 6 | 1 |